Aside from utilizing chronotherapy as a therapeutic approach, the group found that the CLOCK level was downregulated in ALDH+ cells in the murine 4T1 breast cancer cells, and overexpression of CLOCK markedly inhibited the tumorigenicity and invasive capacities of these breast cancer cells. Here, CLOCK is linked to breast carcinoma.